Table 3 Pre-hospital PCCD Use for All Pelvic Fractures at Level 1 Trauma Centers
|
Apply PCCD to All Pelvic Fractures n = 11 |
Do not Apply PCCD to All Pelvic Fractures n = 14 | p | |
|---|---|---|---|
| Guideline followed | |||
| EAST | 38% (3) | 63% (5) | 0.89 |
| WTA | 50% (2) | 50% (2) | |
| TQIP | 0% (0) | 100% (2) | |
| ATLS | 50% (1) | 50% (1) | |
| MTP in Guideline? | |||
| Yes | 55% (6) | 71% (10) | 0.43 |
| No | 45% (5) | 29% (4) | |
| Other Blood Products in Guideline? | |||
| Yes | 45% (5) | 43% (6) | > 0.99 |
| No | 55% (6) | 57% (8) | |
| Region | |||
| Midwest | 63% (3) | 38% (5) | 0.36 |
| Northeast | 75% (3) | 25% (1) | |
| South | 25% (2) | 75% (6) | |
| West | 60% (3) | 40% (2) | |
| Length in time as an ACS-Verified Level 1 Center | |||
| < 1 year | 50% (1) | 50% (1) | 0.36 |
| ≥ 1 year to 2 years | 0 | 100% (3) | |
| ≥ 2 years to 5 years | 33% (2) | 67% (4) | |
| ≥ 5 years to 10 years | 100% (1) | 0 | |
| ≥ 10 years | 54% (7) | 46% (6) | |
| Volume of Trauma Admissions in 2017 | |||
| Low-volume | 100% (1) | 0 | > 0.99 |
| High-volume | 46% (11) | 54% (13) | |